Breakthrough data from Vatiquinone trials propels PTC Therapeutics stock to 52-week high
PTC Therapeutics Inc. (NASDAQ: PTCT) is experiencing significant momentum within the biotechnology sector following a surge in its stock price to a 52-week high of ... Read More
Huntington’s Disease : Understanding Its Impacts and Treatments
Huntington's disease is a severe neurodegenerative disorder, characterized by its autosomal dominant inheritance pattern. This condition leads to progressive brain degeneration starting in adulthood, resulting ... Read More
Teva Pharmaceutical gets FDA approval for AUSTEDO XR for TD and HD
Teva Pharmaceutical Industries said that its US affiliate Teva Pharmaceuticals has secured approval for AUSTEDO XR (deutetrabenazine) extended-release tablets from the US Food and Drug ... Read More